BACKGROUND: Food allergy, in particular peanut allergy, is a growing concern in Western countries. The prevalence of allergy to peanut, which currently stands at 1.4%, nearly tripled between 1997 and 2008. Allergic sensitization is a particularly difficult process to study as it is clinically silent. We sought to identify key pathways and mediators critically involved in the induction of allergic sensitization to peanut. METHODS: Comprehensive metabolomics analysis with liquid chromatography-mass spectrometry was used to detect metabolite changes in mice (C57BL/6) undergoing sensitization. Loss-of-function and gain-of-function studies were performed in mice subjected to two models of peanut sensitization and anaphylaxis that involved either oral or epicutaneous sensitization. Flow cytometric analyses on dendritic cells (DCs) in vitro and in vivo were used to investigate the mechanisms of immune activation. RESULTS: Elevated levels of uric acid (UA) were detected in mice undergoing sensitization as well as in peanut-allergic children who were not challenged with peanut. In mice, the depletion of UA during sensitization prevented the development of peanut-specific immunoglobulins IgE and IgG1 as well as anaphylaxis while exogenous delivery of UA crystals (monosodium urate, MSU) restored the allergic phenotype. Monosodium urate enhanced CD86 and OX40L expression on DCs, independent of Toll-like receptors 2 and 4, the NLRP3 inflammasome, and IL-1β, via a PI3K signaling pathway. CONCLUSION: Overproduction of the UA alarmin in the local microenvironment plays a critical role in the induction of peanut-allergic sensitization, likely due to its ability to activate DCs. These finding suggest that cellular damage or tissue injury may be an essential requisite for the development of allergic sensitization to foods.
BACKGROUND: Food allergy, in particular peanutallergy, is a growing concern in Western countries. The prevalence of allergy to peanut, which currently stands at 1.4%, nearly tripled between 1997 and 2008. Allergic sensitization is a particularly difficult process to study as it is clinically silent. We sought to identify key pathways and mediators critically involved in the induction of allergic sensitization to peanut. METHODS: Comprehensive metabolomics analysis with liquid chromatography-mass spectrometry was used to detect metabolite changes in mice (C57BL/6) undergoing sensitization. Loss-of-function and gain-of-function studies were performed in mice subjected to two models of peanut sensitization and anaphylaxis that involved either oral or epicutaneous sensitization. Flow cytometric analyses on dendritic cells (DCs) in vitro and in vivo were used to investigate the mechanisms of immune activation. RESULTS: Elevated levels of uric acid (UA) were detected in mice undergoing sensitization as well as in peanut-allergic children who were not challenged with peanut. In mice, the depletion of UA during sensitization prevented the development of peanut-specific immunoglobulins IgE and IgG1 as well as anaphylaxis while exogenous delivery of UA crystals (monosodium urate, MSU) restored the allergic phenotype. Monosodium urate enhanced CD86 and OX40L expression on DCs, independent of Toll-like receptors 2 and 4, the NLRP3 inflammasome, and IL-1β, via a PI3K signaling pathway. CONCLUSION: Overproduction of the UA alarmin in the local microenvironment plays a critical role in the induction of peanut-allergic sensitization, likely due to its ability to activate DCs. These finding suggest that cellular damage or tissue injury may be an essential requisite for the development of allergic sensitization to foods.
Authors: M Fazlollahi; Y Chun; A Grishin; R A Wood; A W Burks; P Dawson; S M Jones; D Y M Leung; H A Sampson; S H Sicherer; S Bunyavanich Journal: Allergy Date: 2018-03-15 Impact factor: 13.146
Authors: Rodrigo Jiménez-Saiz; Derek K Chu; Talveer S Mandur; Tina D Walker; Melissa E Gordon; Roopali Chaudhary; Joshua Koenig; Sarah Saliba; Heather J Galipeau; Adam Utley; Irah L King; Kelvin Lee; Rachel Ettinger; Susan Waserman; Roland Kolbeck; Manel Jordana Journal: J Allergy Clin Immunol Date: 2017-02-16 Impact factor: 10.793
Authors: M Bol-Schoenmakers; S Braber; P Akbari; P de Graaff; M van Roest; L Kruijssen; J J Smit; B C A M van Esch; P V Jeurink; J Garssen; J Fink-Gremmels; R H H Pieters Journal: Mucosal Immunol Date: 2016-02-17 Impact factor: 7.313
Authors: Jolanda H M van Bilsen; Edyta Sienkiewicz-Szłapka; Daniel Lozano-Ojalvo; Linette E M Willemsen; Celia M Antunes; Elena Molina; Joost J Smit; Barbara Wróblewska; Harry J Wichers; Edward F Knol; Gregory S Ladics; Raymond H H Pieters; Sandra Denery-Papini; Yvonne M Vissers; Simona L Bavaro; Colette Larré; Kitty C M Verhoeckx; Erwin L Roggen Journal: Clin Transl Allergy Date: 2017-05-12 Impact factor: 5.871
Authors: Isabel J Skypala; Ricardo Asero; Domingo Barber; Lorenzo Cecchi; Arazeli Diaz Perales; Karin Hoffmann-Sommergruber; Elide A Pastorello; Ines Swoboda; Joan Bartra; Didier G Ebo; Margaretha A Faber; Montserrat Fernández-Rivas; Francesca Gomez; Anastasios P Konstantinopoulos; Olga Luengo; Ronald van Ree; Enrico Scala; Stephen J Till Journal: Clin Transl Allergy Date: 2021-05-18 Impact factor: 5.871
Authors: Katrine Lindholm Bøgh; Jolanda van Bilsen; Robert Głogowski; Iván López-Expósito; Grégory Bouchaud; Carine Blanchard; Marie Bodinier; Joost Smit; Raymond Pieters; Shanna Bastiaan-Net; Nicole de Wit; Eva Untersmayr; Karine Adel-Patient; Leon Knippels; Michelle M Epstein; Mario Noti; Unni Cecilie Nygaard; Ian Kimber; Kitty Verhoeckx; Liam O'Mahony Journal: Clin Transl Allergy Date: 2016-06-16 Impact factor: 5.871